MAPT and Alzheimer disease: Alzheimer’s disease (AD) is pathologically characterized by the accumulation of beta amyloid (Aβ), a peptide of 40 or 42 amino acids, in extracellular senile plaques, as well as intracellular neurofibrillary tangles (NFTs) mainly consisting of tau protein [1,2].